BrainStorm Cell Therapeutics GAAP EPS of -$1.11 beats by $0.50
Source: SeekingAlpha
2026-03-31 16:31:11 ET
More on BrainStorm Cell Therapeutics
- Brainstorm Cell secures $1M strategic financing
- Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics
- Historical earnings data for BrainStorm Cell Therapeutics
- Financial information for BrainStorm Cell Therapeutics
Read the full article on Seeking Alpha
For further details see:
BrainStorm Cell Therapeutics GAAP EPS of -$1.11 beats by $0.50
Brainstorm Cell Therapeutics Inc.
NASDAQ: BCLI
BCLI Trading
0.71% G/L:
$0.871 Last:
11,992 Volume:
$0.865 Open:
BCLI Latest News
March 31, 2026 04:01:00 pm
BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate UpdateFebruary 26, 2026 06:22:00 am
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In FebruaryFebruary 20, 2026 06:00:00 am
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to MarketBCLI Stock Data
$6,179,474
9,804,398
11.34%
6
566390%
Biotechnology & Life Sciences
Healthcare
US
New York
